All Posts: News Release
-
Georgetown Announces Phase II Clinical Trial of Nilotinib for Parkinson’s Disease
Georgetown University Medical Center (GUMC) today announces the launch of a phase II clinical trial to study the safety of the cancer drug nilotinib and its effects on clinical outcomes and biomarkers in people with Parkinson’s disease.
Category: News Release
-
Smoking Cessation Counseling Successful When Paired with Lung Cancer Screening
In the first successful randomized trial of its kind, Georgetown Lombardi Comprehensive Cancer Center researchers have provided preliminary evidence that telephone-based smoking cessation counseling given to smokers shortly after undergoing lung cancer screening can be effective at helping people stop smoking.
Category: News Release
-
First Ever Real-Time Efficacy Study on Fertility App Launched
In what is believed to be the first study of its kind, researchers at Georgetown University Medical Center’s Institute for Reproductive Health (IRH) announced today the launch of a year-long study to measure the efficacy of a new app, Dot™, for avoiding unintended pregnancy as compared to efficacy rates of other family planning methods.
Category: News Release
-
Toward Understanding When Eating Soy Might Help or Harm In Breast Cancer Treatment
Georgetown Lombardi Comprehensive Cancer Center researchers have used animal models to reveal new information about the impact – positive and negative – that soy consumption could have on a common breast cancer treatment.
Category: News Release
-
Mindfulness Meditation Training Lowers Biomarkers of Stress Response in Anxiety Disorder
GUMC researchers found that anxiety disorder patients had sharply reduced stress-hormone and inflammatory responses to a stressful situation after taking a mindfulness meditation course—whereas patients who took a non-meditation stress management course had worsened responses.
Category: News Release
-
Scientists Describe Lab Technique With Potential To Change Medicine and Research
Researchers who developed and tested a revolutionary laboratory technique that allows for the endless growth of normal and diseased cells in a laboratory are publicly sharing how the technique works.
Category: News Release
-
Georgetown Clinical Trial Testing Nilotinib in Alzheimer’s Disease Begins
A clinical trial to examine the effect of nilotinib on clinical outcomes and biomarkers in people with mild to moderate Alzheimer’s disease has opened at Georgetown University Medical Center (GUMC).
Category: News Release
-
Large Pre-ACA Medicaid Expansion Did Not Level Health Disparities in Cancer Surgery
An analysis of the New York State’s Medicaid expansion, which predated the 2010 Affordable Care Act, finds substantial decrease in uninsured rate but little change in racial disparities when it comes to access to cancer surgery – a proxy for complex cancer care.
Category: News Release
-
Pandemic Preparedness in the Next Administration
As the United States prepares for new leadership, global health thought leaders will convene January 10 to discuss ways the Trump administration can contribute to pandemic preparedness, global health security, and domestic readiness and resilience.
Category: News Release
-
Steroid Originally Discovered in the Dogfish Shark Attacks Parkinson’s-Related Toxin in Animal Model
A naturally occurring steroid made by the dogfish shark prevents the buildup of a lethal protein in animal studies, reports an international team of researchers. The clustering of this protein, alpha-synuclein (α-synuclein), is the hallmark of Parkinson’s disease and dementia with Lewy bodies, suggesting a new potential compound for therapeutic research.
Category: News Release